|
Market Cap (2-Jul) $363,897,504 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 14 March 2023, 8:11. The announcement is marked as price sensitive, and is 3 page(s) in length and 219.54kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.367% short sold according to ASIC data. It was ranked the 352nd most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Initiation of Ph 2/3 Trial for Metastatic Breast Cancer | 14 March 2023, 8:11 |
| Half Yearly Report and Accounts | 24 February 2023, 18:57 |
| Enrolment Target Reached for INSIGHT-003 Trial in NSCLC | 6 February 2023, 8:48 |
| Immutep Quarterly Activities Report and Appendix 4C | 30 January 2023, 8:34 |
You must be logged in to post a reply.
